Substances · Cathinone derivatives
4-CMC
- Preferred name
- 4-CMC
- IUPAC name
- 1-(4-chlorophenyl)-2-(methylamino)propan-1-one
- Parent CAS number (reference)
- 1225843-86-6
- Molecular formula
- C10H12ClNO
- Molecular weight
- 197.66 g/mol
- InChIKey
- UEJBEYOXRNGPEI-UHFFFAOYSA-N
- PubChem
- CID 82100418
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
Clephedrone 4-Chloromethcathinone 4CMC 4 CMC
Verified Neurochemical & Toxicological Intelligence
4-CMC (Clephedrone / 4-Chloromethcathinone)
Receptor Telemetry & Mechanism of Action
Functions primarily as a substrate-type serotonin-norepinephrine-dopamine releasing agent (SNDRA) with low SERT/DAT selectivity (~3.4) closely resembling mephedrone (4-MMC). In rat brain synaptosomes (Walther et al., 2018), 4-CMC releases dopamine (DAT EC50 = 42.2 nM), norepinephrine (NET EC50 = 44 ± 9 nM), and serotonin (SERT EC50 = 144 nM), alongside moderate uptake inhibition (IC50: 208 nM DAT, 670 nM SERT). Para-chlorination shifts subjective feel toward warm, dreamy serotonergic mood elevation, though preclinical studies indicate elevated oxidative stress and cytotoxicity relative to 4-MMC.
Biotransformation & Active Metabolites
Metabolized via N-demethylation to 4-chlorocathinone and carbonyl reduction to dihydro-4-CMC. Human observational oral studies (75–150 mg) reveal a significantly delayed oral-fluid concentration peak and delayed onset of subjective and cardiovascular effects compared to methylone.
Temporal Pharmacokinetics
Warm, soothing, serotonergic-leaning entactogen-stimulant producing emotional openness, tactile enhancement, relaxed body mood elevation, and moderate sociability with less sharp motor drive than 3-CMC.
- Onset 20–60 minutes oral (delayed absorption relative to methylone; 10–30 minutes mucosal)
- Peak Window 1–2 hours
- Total Window 2–4 hours oral (vital-sign and cortisol shifts persist across 5 hours; 1–2 hours mucosal)
- Residual / Half-Life 3–12 hours of insomnia, serotonergic fatigue, and mood dip; exact human elimination half-life is unverified.
Critical delayed-onset hazard: human observational studies confirm that oral 4-CMC reaches peak fluid levels and peak subjective effects noticeably later than methylone. repeated exposure during the first 45–60 minutes because 'nothing is happening yet' frequently causes abrupt, overwhelming serotonergic-sympathomimetic toxicity, hyperthermia, and oxidative stress.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
20–30 mg
Gentle mood softening, mild anxiety reduction, and subtle sensory brightening.
Slight warmth in the chest and extremities with minimal pulse shift.
30–50 mg
Relaxed sociability, mild tactile pleasure, emotional comfort, and light music enhancement.
Modest elevation in heart rate, slight pupil dilation, and mild dry mouth.
50–100 mg (human observational cohorts tested 75–150 mg)
Distinct 4-MMC-like serotonergic warmth, empathy, lowered inhibitions, heightened libido, and dreamy contentment.
Dilated pupils with slowed pupillary light reflex, elevated systolic blood pressure and heart rate, sweating, jaw clenching, and mild balance softening.
100–150 mg
Heavy, sedating-mood-elevating immersion, slurred or slowed speech, short-term memory lapses, and disorientation.
Strong bruxism, hyperthermia, nausea on come-up, impaired balance (positive Romberg sign), and marked peripheral vasoconstriction.
150–180+ mg
Acute agitation, fear, hallucinations, aggression, serotonergic delirium, or psychotic episodes.
Severe hyperthermia, chest pain, arrhythmias, hypertension, seizures, oxidative neurotoxicity, and multi-organ stress.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Potent serotonin and catecholamine release from 4-CMC combined with MAO blockade precipitates rapid, fatal serotonin syndrome and hypertensive crisis.
High SERT release potency (EC50 = 144 nM) makes additive serotonergic combinations prone to life-threatening hyperthermia, clonus, and seizures.
Synergistic hypertension, vasospasm, and cardiac strain elevate risk of stroke or cardiac arrest.
Elevated Hazard — Avoid
Compounds dehydration, motor ataxia, oxidative burden, and delayed depressant rebound once 4-CMC wears off.
Heightens thermoregulatory strain, vasoconstriction, and acute anxiety during 4-CMC's rapid offset.
Caution / Receptor Attenuation
Blocks SERT-mediated serotonin efflux, muting 4-CMC's signature empathogenic warmth while retaining cardiovascular side effects and serotonin-toxicity risk at high amounts.
Can intensify dizziness, tachycardia, and short-term confusion during peak or comedown.
Structural Isomer & Sibling Comparison
4-CMC is the most serotonergic of the three chloromethcathinone isomers (SERT EC50 144 nM vs. 211 nM for 3-CMC and 2,815 nM for 2-CMC), giving it a softer, warmer, more 'rolly' feel than brisk, dopaminergic 3-CMC and plain-stimulant 2-CMC. Compared to 4-MMC (mephedrone), 4-CMC has lower standard oral reference brackets on TripSit (50–100 mg vs. 100–200 mg) while feeling shorter, slower to peak orally, and carrying stronger preclinical cytotoxicity and oxidative-stress signals.
Physicochemical Stability & Storage
Physical Form: White, off-white, or pale yellowish crystalline solid or translucent crystal chunks as the hydrochloride salt (mp ~198 °C). · Soluble in PBS (pH 7.2, ~5 mg/mL), ethanol (~5 mg/mL), DMF (~5 mg/mL), and DMSO (~10 mg/mL).
Unstable in warm aqueous or biological matrices due to beta-keto reduction; store dry in an airtight, light-protected container at cool or sub-zero temperatures.
Cross-Tolerance & Dependence Profile
Rapid tolerance to serotonergic mood elevation within a single session, with cross-tolerance across all cathinones, MDMA, and amphetamines. Because para-chlorinated cathinones induce marked cytotoxicity and oxidative stress in vitro, frequent or back-to-back sessions carry heightened neurochemical risks; multi-week recovery intervals are strongly advised.
Codes on this card
Short meanings for the abbreviations printed with this substance.
DAT
Dopamine transporter
DAT is the protein that collects dopamine back from the gap between nerve cells. A card that names DAT is quoting a laboratory result about that protein.
NET
Norepinephrine transporter
NET is the protein that collects norepinephrine, also called noradrenaline, back into the nerve cell. Cards cite it when a lab report shows activity at that transporter.
SERT
Serotonin transporter
SERT is the protein that collects serotonin back into the nerve cell. A higher number than at DAT means the serotonin transporter needed more concentration to reach the halfway point.
SNDRA / NDRI
Releaser or reuptake blocker
An SNDRA is carried in and the cell releases serotonin, norepinephrine, and dopamine. An NDRI mainly slows the vacuum at norepinephrine and dopamine. The class line says which one the papers describe.
EC₅₀ / IC₅₀
Halfway concentration
EC50 is the concentration where a lab saw half of the maximum measured effect. IC50 is the concentration where it saw half of the maximum block. Smaller means that halfway point came at a lower concentration.
isomer
Isomers
Isomers share the same atoms in the same counts, but the atoms are arranged differently. They can share a molecular formula and still be different chemicals, with different CAS numbers and different lab results.
5-HT ↑↑
Serotonergic Overload (Serotonin Toxicity)
A potentially fatal medical emergency caused by excessive synaptic serotonin (for example when mixing two serotonin releasers, MAOIs, or tramadol), marked by hyperthermia and neuromuscular rigidity.
HR / Naczynia
Vasoconstriction & Cardiovascular Load
Narrowing of peripheral blood vessels, elevated blood pressure, and rapid heart rate driven by strong noradrenergic and dopaminergic stimulation.
Chemical Architecture & Structural Profile
4-CMC (1-(4-chlorophenyl)-2-(methylamino)propan-1-one) is a reference compound belonging to the Cathinone derivatives class, characterized by the molecular formula C10H12ClNO and a molar mass of 197.66 g/mol. The parent molecule is indexed under CAS registry number 1225843-86-6 and in the NCBI PubChem database as CID 82100418 (Standard InChIKey: UEJBEYOXRNGPEI-UHFFFAOYSA-N). This molecule shares its empirical formula (C10H12ClNO) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (1225843-86-6), and spectroscopic profile.
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 4-CMC is indexed within the Cathinone derivatives structural group. As a substituted beta-ketone (cathinone derivative), this compound requires strict analytical verification and has documented contraindications with MAOIs, serotonergic agents, and other stimulants. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- Riksdagen — Förordning (1999:58) om förbud mot vissa hälsofarliga varor — Sveriges riksdag (2026-11-12)